Contact Us marketing@medicilon.com
Medicilon Logo
|
search icon search icon 中 contact icon menu icon
Medicilon Logo
|
search icon close search icon 中 contact icon menu icon
ABOUT
Company Profile
Corporate Culture
Management Team
Company History
Message from the CEO
Honors and Awards
Over 20 years of experience in R&D
Learn more
01 Drug Discovery
Chemistry Research
Biology Research
Early Pharmacokinetics
02 Pharmaceutical Research
Intermediates
Active Pharmaceutical Ingredients
Pharmaceutical preparation
Analytical Method Development and Quality Control
CMC Filings
Analytical Testing Center
03 Preclinical Research
Pharmacology & Pharmacodynamics
Drug Safety Evaluation
DMPK
Bioanalysis
IND Filings
01 One-stop Integrated Services
Liposome Drug Development
Drug Discovery
Pharmaceutical Research
Preclinical Research
Botanical Drug Preclinical R&D
02 Innovative Drug Services
ADC
PROTAC
mRNA Vaccine
Cellular Immunotherapies
Nucleic Acid Drug
Peptide Drug Conjugate (PDC)
Antibody
03 Key Technical Services for Drug R&D
Cytokine and Biomarker Detection
Metabolite Identification (MetID)
Drug Forming Research
Flow Cytometry Technology
SEND Format Conversion
Flow Sorting
NanoString nCounter Detection
Routes of Drug Administration
04 Drug Efficacy Evaluation for Common Diseases
IO Pharmacodynamic Model
Inflammatory and Immune Diseases
Rodent Cerebrovascular Disease
05 Advanced Preparation R&D
Inhalation drug
Ophthalmic drug
Skin Topical Preparation
06 Targeted Drugs R&D Services
STAT3-targeted Drugs R&D Service
GLP-1 New Drug R&D Service
KRAS-targeted Drugs R&D Service
CAREERS
Talent Development
Campus Recruitment
Recruitment
Campus Recruitment
Campus Recruitment
Recruitment
Recruitment
News
Medicilon Events
Featured Stories
Market Events
Videos
A.C.E.
2024-07-22Medicilon Events
The Shanghai Overseas Returned Scholars Association invites the Dutch PhD delegation to visit Medicilon, exploring paths for innovative development together
On July 4th, the Shanghai Overseas Returned Scholars Association invited the Dutch PhD delegation to visit the Chuansha campus of Shanghai Medicilon Inc. (Medicilon) and held discussions with Medicilon's Founder and CEO, Chunlin Chen, among others.
Learn more
2024-07-22Medicilon Events
5th consecutive win! Medicilon once again made the list of "Top 20 Chinese R&D CRO Enterprises in 2024"
Medicilon stood out among hundreds of pharmaceutical enterprises and was honored with the "Top 20 Chinese R&D CRO Enterprises in 2024" award.
Learn more
INVESTORS
Stock Information
Investment Contact
Medicilon 688202
RMB

As of Beijing time The data is from a third-party organization and is only for reference.

For actual information, please refer to：www.eastmoney.com

CLIENT CENTER
Intellectual Property Protection
Clients Testimonials
Downloads
Partnerships
Medicilon Support
Newsletters
U.S.

Address: 20 Maguire Road, Suite 103, Lexington, MA 02421(America)

Tel: +1(626)986-9880

UK

Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK

Tel: 0044 7790 816 954

Email: marketing@medicilon.com

China

Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters)

Postcode: 201299

Tel: +86 (21) 5859-1500 (main line)

Fax: +86 (21) 5859-6369

Close

© 2023 Shanghai Medicilon Inc. All rights reserved Shanghai ICP No.10216606-3

Shanghai Public Network Security File No. 31011502018888 | Website Map

© 2023 Shanghai Medicilon Inc. All rights reserved Shanghai ICP No.10216606-3
Shanghai Public Network Security File No. 31011502018888|Website Map
关闭
中
Message
Contact Us
Close Button
Back To Top
Online Message×
Click switch
Close Button
News and Events
Medicilon Events Featured Stories Market Events Videos A.C.E.
HomenewsFeatured Stories

Featured Stories

Hot information：
Top 10 Global CDMO Enterprises| The Meaning of IND, NDA and ANDA| Top 10 Global Clinical Research Organizations in 2021
Nov 09,2017
Stem Cell Restoration of Hearing Loss Might Be a Double-Edged Sword
Stem cells have been a boon to biological research, allowing researchers to visualize and develop potential therapies for diseases where intervention has hit a wall. However, not all stem cell therapies are as simple as adding undifferentiated cells to damaged areas, allowing natural biological processes to take hold.   For instance, inner ear stem cellsRead more
More
Nov 09,2017
Cancer Chemotherapy Resistance Stopped By Chromatin Regulation
Researchers at Northwestern University have developed a new approach to treating cancer that effectively changes the physical structure of chromatin and blocks the cell's ability to modify global gene expression patterns and evolve resistance to therapy. The researchers, led by Vadim Backman, Ph.D., the Walter Dill Scott Professor of Biomedical Engineering at Northwestern's McCormick SchoolRead more
More
Cancer Chemotherapy Resistance Stopped By Chromatin Regulation
Nov 09,2017
Principles and types of ELISA
The principle of ELISA The basis of ELISA is the immobilization of antigen or antibody and the enzyme labeling of antigen or antibody. The antigen or antibody bound to the surface of the solid phase carrier still maintains its immunological activity, and the enzyme-labeled antigen or antibody retains both its immunological activity and enzyme
More
Principles and types of ELISA
Nov 08,2017
Cheating Chromosomes Vault Past Competitors to Reach Egg Cell First
Each of your cells contains two copies of 23 chromosomes, one inherited from your father and one from your mother. Theoretically, when you create a gamete – a sperm or an egg – each copy has a 50-50 shot at being passed on. But the reality isn't so clear cut.   Studies by scientists atRead more
More
Nov 08,2017
Liquid Biopsy Improved for Characterization of Metastatic Tumors
The promise of advanced, minimally invasive techniques, such as liquid biopsy, for diagnosing and tracking cancer progression has pushed researchers to develop accurate, scalable approaches for monitoring cancer DNA from blood samples.   Now, investigators at the Broad Institute of MIT and Harvard, Koch Institute at MIT, Dana-Farber Cancer Institute (DFCI), and Massachusetts General HospitalRead more
More
Nov 07,2017
Lab-Designed Molecules Offer New Approach to Treating Superbug Infections
A team led by researchers from the Spanish National Research Council (CSIC) has made an important breakthrough in the battle against superbugs and their resistance to multiple drugs. Scientists have designed molecules that can break the cellular mechanisms of bacterial resistance conventional antibiotics. The results of this discovery ("Membrane Microdomain Disassembly Inhibits MRSA Antibiotic Resistance”)Read more
More
Lab-Designed Molecules Offer New Approach to Treating Superbug Infections
Nov 07,2017
Tuning the Microbiome Improves Melanoma Immunotherapy Response
Bacteria that live in the human digestive tract can influence how cancer responds to immunotherapy, opening a new avenue for research to improve treatment, a team led by researchers at The University of Texas MD Anderson Cancer Center reports in the journal Science.  Findings from the new study – ("Gut Microbiome Modulates Response to Anti–PD-1Read more
More
Tuning the Microbiome Improves Melanoma Immunotherapy Response
Nov 07,2017
Single Cell Western Blot
A new approach to study protein expression on a cell-by-cell basis. Almost all cells studied in vitro and in vivo, including stem cells and cancer cells, do not represent a homogenous population but are inherently heterogeneous at a molecular level. The biological department of Shanghai Medicilon has extensive experience in the field of in vitroRead more
More
Single Cell Western Blot
Nov 06,2017
Stem Cell Subset Source of All Blood Cells, Basis of Bone Marrow Transplant Success
A new blood system isn't created from scratch – just something close to it. A single type of stem cell, a new study demonstrates, can fully repopulate the bone marrow and give rise to all the cell lineages that constitute a complete blood system.   This blood-forming stem cell is distinguished by three cell-surface markersRead more
More
Nov 06,2017
New DNA Repair Mechanism in Tuberculosis Uncovered
Tuberculosis (TB) remains a significant threat to much of the world's population – affecting up to two billion people annually. It has sat, unwavering, near the top of the list for deadliest diseases. Moreover, current therapeutics to treat the disease is becoming increasingly ineffective as drug resistance continues to rise exponentially.   Now, new researchRead more
More
Stock Code
688202

Global

Address: 20 Maguire Road, Suite 103, Lexington, MA 02421(America)

Tel: +1(626)986-9880(U.S.)

Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK

Tel: 0044 7790 816 954 (Europe)

Email: marketing@medicilon.com

  

Address: 5th Floor, 62, Banpodae-ro 4-gil, Seocho-gu, Seoul, 06719 South Korea

Tel: +82 70-8269-5849

China

Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters)

Postcode: 201299

Tel: +86 (21) 5859-1500 (main line)

Fax: +86 (21) 5859-6369

Facebook icon
Twitter icon
Linkedin icon
Youtube icon
© 2023 Shanghai Medicilon Inc. All rights reserved All Rights Reserved Privacy Policy
Website Map
-->